{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T02:10:06Z","timestamp":1756433406444,"version":"3.44.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004330","name":"GSK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue des Maladies Respiratoires"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.rmr.2025.05.003","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T09:15:18Z","timestamp":1750238118000},"page":"331-342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Usage en vie r\u00e9elle de l\u2019association fixe fluticasone\/umeclidinium\/vilanterol en France. Une \u00e9tude de population sur le Syst\u00e8me National des Donn\u00e9es de Sant\u00e9"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9063-9881","authenticated-orcid":false,"given":"B.","family":"Aguilaniu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6601-1288","authenticated-orcid":false,"given":"J.","family":"Cittee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4057-1102","authenticated-orcid":false,"given":"L.","family":"Watier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3126-0572","authenticated-orcid":false,"given":"C.","family":"Pribil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5116-0723","authenticated-orcid":false,"given":"G.","family":"Nachbaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1716-4660","authenticated-orcid":false,"given":"L.","family":"Sa\u00efl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3291-4328","authenticated-orcid":false,"given":"A.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0021-9005","authenticated-orcid":false,"given":"A.","family":"Panes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Jebrak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmr.2025.05.003_bib0150","doi-asserted-by":"crossref","first-page":"15003","DOI":"10.7189\/jogh.11.15003","article-title":"Research priorities to address the global burden of chronic obstructive pulmonary disease (COPD) in the next decade","volume":"11","author":"Adeloye","year":"2021","journal-title":"J Glob Health"},{"key":"10.1016\/j.rmr.2025.05.003_bib0155","unstructured":"Masson E. EM-Consulte. [cit\u00e9 6 juin 2025]. Prise en charge et co\u00fbts de la bronchopneumopathie chronique obstructive en France en 2011. Disponible sur:\u00a0: https:\/\/www.em-consulte.com\/article\/1001241\/prise-en-charge-et-couts-de-la-bronchopneumopathie."},{"key":"10.1016\/j.rmr.2025.05.003_bib0160","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1055\/s-2005-869539","article-title":"Epidemiology and global impact of chronic obstructive pulmonary disease","volume":"26","author":"Mannino","year":"2005","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2025.05.003_bib0165","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S2213-2600(20)30105-3","article-title":"Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"8","author":"Soriano","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmr.2025.05.003_bib0170","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3109\/15412555.2010.481697","article-title":"The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review","volume":"7","author":"Toy","year":"2010","journal-title":"COPD"},{"key":"10.1016\/j.rmr.2025.05.003_bib0175","unstructured":"Haute Autorit\u00e9 de sant\u00e9 (HAS). Haute Autorit\u00e9 de sant\u00e9. [cit\u00e9 7\u00a0mai 2023]. Guide du parcours de soins bronchopneumopathie chronique obstructive (BPCO). Disponible sur\u00a0: https:\/\/www.has-sante.fr\/jcms\/c_1242507\/fr\/guide-du-parcours-de-soins-bronchopneumopathie-chronique-obstructive-bpco."},{"key":"10.1016\/j.rmr.2025.05.003_bib0180","first-page":"1710","article-title":"Docteur, j\u2019ai peur d\u2019\u00e9touffer\u00a0! BPCO et manifestations psychiatriques","volume":"577","author":"Henninger","year":"2017","journal-title":"Rev Med Suisse"},{"key":"10.1016\/j.rmr.2025.05.003_bib0185","series-title":"Position de la SPLF Actualisation","article-title":"Optimisation du traitement m\u00e9dicamenteux des patients atteints de BPCO en \u00e9tat stable","author":"Zysman","year":"2021"},{"key":"10.1016\/j.rmr.2025.05.003_bib0190","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/j.respe.2017.05.004","article-title":"Value of a national administrative database to guide public decisions: from the Syst\u00e8me national d\u2019information interr\u00e9gimes de l\u2019Assurance Maladie (SNIIRAM) to the syst\u00e8me national des donn\u00e9es de sant\u00e9 (SNDS) in France","volume":"65","author":"Tuppin","year":"2017","journal-title":"Rev Epidemiol Sante Publique"},{"first-page":"2021","year":"2019","series-title":"M\u00e9thodologie m\u00e9dicale de la cartographie des pathologies et des d\u00e9penses, version G8 (ann\u00e9es 2015\u00a0\u00e0 tous r\u00e9gimes) [Internet]","key":"10.1016\/j.rmr.2025.05.003_bib0195"},{"key":"10.1016\/j.rmr.2025.05.003_bib0205","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2458-9-33","article-title":"Ecological association between a deprivation index and mortality in France over the period 1997-2001: variations with spatial scale, degree of urbanicity, age, gender and cause of death","volume":"9","author":"Rey","year":"2009","journal-title":"BMC Public Health"},{"key":"10.1016\/j.rmr.2025.05.003_bib0210","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/MLR.0000000000000471","article-title":"The best use of the Charlson Comorbidity Index with electronic health care database to predict mortality","volume":"54","author":"Bannay","year":"2016","journal-title":"Med Care"},{"key":"10.1016\/j.rmr.2025.05.003_bib0215","unstructured":"Hospitalisations pour exacerbations de BPCO. Comment les identifier \u00e0 partir des donn\u00e9es du programme de m\u00e9dicalisation des syst\u00e8mes d\u2019information (PMSI)\u00a0? [Internet]. [cit\u00e9 28\u00a0sept 2021]. Disponible sur\u00a0: https:\/\/www.santepubliquefrance.fr\/maladies-et-traumatismes\/maladies-et-infections-respiratoires\/bpco-et-insuffisance-respiratoire-chronique\/documents\/rapport-synthese\/hospitalisations-pour-exacerbations-de-bpco.-comment-les-identifier-a-partir-des-donnees-du-programme-de-medicalisation-des-systemes-d-information."},{"key":"10.1016\/j.rmr.2025.05.003_bib0220","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1016\/j.respe.2019.04.007","article-title":"Analyses des s\u00e9quences de traitements \u00e0 partir du Sniiram\u00a0: cas d\u2019\u00e9tude des incidents 2013\u00a0du VIH","volume":"67","author":"Laurent","year":"2019","journal-title":"Rev Epidemiol Sante Publ"},{"key":"10.1016\/j.rmr.2025.05.003_bib0225","doi-asserted-by":"crossref","first-page":"100717","DOI":"10.1016\/j.lanepe.2023.100717","article-title":"Health trajectories before initiation of non-invasive ventilation for chronic obstructive pulmonary disease: a French nationwide database analysis","volume":"34","author":"Pepin","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.rmr.2025.05.003_bib0230","doi-asserted-by":"crossref","first-page":"e001150","DOI":"10.1136\/bmjresp-2021-001150","article-title":"Differences in severe exacerbations rates and healthcare utilisation in COPD populations in the UK and France","volume":"9","author":"Whittaker","year":"2022","journal-title":"BMJ Open Resp Res"},{"key":"10.1016\/j.rmr.2025.05.003_bib0235","first-page":"621","article-title":"Hospitalizations for COPD exacerbations: trends and determinants of death","volume":"12","author":"Molinari","year":"2015","journal-title":"COPD"},{"key":"10.1016\/j.rmr.2025.05.003_bib0240","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2147\/COPD.S238933","article-title":"The association between neighborhood socioeconomic disadvantage and chronic obstructive pulmonary disease","volume":"15","author":"Galiatsatos","year":"2020","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.rmr.2025.05.003_bib0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2296-14-11","article-title":"Comorbidity in patients with chronic obstructive pulmonary disease in family practice: a cross sectional study","volume":"14","author":"Garc\u00eda-Olmos","year":"2013","journal-title":"BMC family practice"},{"key":"10.1016\/j.rmr.2025.05.003_bib0250","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.2147\/COPD.S214061","article-title":"Dual versus triple therapy in patients hospitalized for COPD in France: a claims data study","volume":"14","author":"Dalon","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.rmr.2025.05.003_bib0255","doi-asserted-by":"crossref","first-page":"949","DOI":"10.2147\/COPD.S236787","article-title":"Identification of patient profiles with high risk of hospital re-admissions for acute COPD Exacerbations (AECOPD) in France using a machine learning model","volume":"15","author":"Cavailles","year":"2020","journal-title":"COPD"},{"key":"10.1016\/j.rmr.2025.05.003_bib0260","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4046\/trd.2018.0087","article-title":"Utility of computed tomography in a differential diagnosis for the patients with an initial diagnosis of chronic obstructive pulmonary disease exacerbation","volume":"82","author":"Park","year":"2019","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"10.1016\/j.rmr.2025.05.003_bib0265","unstructured":"Global Initiative for Chronic Obstructive Lung Disease - GOLD [Internet]. [cit\u00e9 21\u00a0mars 2025]. 2025\u00a0GOLD Report. Disponible sur\u00a0: https:\/\/goldcopd.org\/2025-gold-report\/."},{"year":"2011","series-title":"EM-Consulte. [cit\u00e9 6 juin 2025]. Prise en charge et co\u00fbts de la bronchopneumopathie chronique obstructive en France","author":"Masson","key":"10.1016\/j.rmr.2025.05.003_bib288"},{"key":"10.1016\/j.rmr.2025.05.003_bib0280","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2213-2600(17)30207-2","article-title":"Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort","volume":"5","author":"Han","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmr.2025.05.003_bib0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12890-018-0684-7","article-title":"Comorbidities and COPD severity in a clinic-based cohort","volume":"18","author":"Raherison","year":"2018","journal-title":"BMC pulmonary medicine"},{"key":"10.1016\/j.rmr.2025.05.003_bib0145","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12931-023-02393-7","article-title":"Pulmonary rehabilitation after severe exacerbation of COPD: a nationwide population study","volume":"24","author":"Guecamburu","year":"2023","journal-title":"Respir Res"}],"container-title":["Revue des Maladies Respiratoires"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842525001871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842525001871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T01:44:54Z","timestamp":1756431894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0761842525001871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0761842525001871"],"URL":"https:\/\/doi.org\/10.1016\/j.rmr.2025.05.003","relation":{},"ISSN":["0761-8425"],"issn-type":[{"type":"print","value":"0761-8425"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Usage en vie r\u00e9elle de l\u2019association fixe fluticasone\/umeclidinium\/vilanterol en France. Une \u00e9tude de population sur le Syst\u00e8me National des Donn\u00e9es de Sant\u00e9","name":"articletitle","label":"Article Title"},{"value":"Revue des Maladies Respiratoires","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmr.2025.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 SPLF. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}